Skip to main content
PYC THERAPEUTICS LIMITED logo

PYC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PYC ISIN · AU000000PYC7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,297 across all filing types
Latest filing 2013-12-02 Capital/Financing Update
Country AU Australia
Listing ASX PYC

About PYC THERAPEUTICS LIMITED

https://pyctx.com/

PYC Therapeutics Limited is a clinical-stage company focused on developing precision medicines for patients with rare genetic diseases. The company utilizes a proprietary drug delivery platform that combines naturally derived cell-penetrating peptides with antisense oligonucleotides to create RNA-based therapeutics. This platform is designed to overcome the challenges of delivering large therapeutic molecules into target cells, particularly within the eye and central nervous system. PYC's primary pipeline includes VP-001, a candidate for Retinitis Pigmentosa type 11, and PYC-001, targeting Autosomal Dominant Optic Atrophy. Additionally, the company is advancing programs for Polycystic Kidney Disease. By leveraging its delivery technology, PYC aims to address the underlying genetic causes of diseases that currently lack effective treatment options.

Recent filings

Filing Released Lang Actions
Letter to Optionholders 2 pages 99.2KB
Capital/Financing Update Classification · 95% confidence The document is a letter dated 3 December 2013 addressed to option holders regarding a non-renounceable entitlement issue of shares by Phylogica Limited. It details the terms of the entitlement issue, the timetable, and instructions for option holders to participate. The document is an announcement about a capital raising event (entitlement issue) and provides information on the offer, record date, and subscription process. It does not contain financial statements or detailed financial analysis but rather informs shareholders and option holders about the capital raising. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is 4314 characters, which is consistent with an announcement rather than a full report.
2013-12-02 English
Entitlement Issue Offer Document 26 pages 160.6KB
Capital/Financing Update Classification · 100% confidence The document is titled 'OFFER DOCUMENT' and describes a pro rata non-renounceable entitlement issue to shareholders, including details about the offer price, underwriting arrangements, timetable, capital structure, and instructions for shareholders to participate. It is a detailed document outlining a capital raising event through a share issue. There is no indication that this is a full annual or interim report, audit report, or earnings release. The document is not a brief announcement but a comprehensive offer document for a share issue. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2013-12-01 English
Entitlement Issue Application for Listing 12 pages 84.1KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the number of shares issued, issue price, purpose of the issue, shareholder approvals, and quotation of securities on the ASX. It includes sections on entitlement issues, placement capacity calculations under ASX Listing Rules 7.1 and 7.1A, and other regulatory compliance details related to new share issues. The content is focused on the announcement and regulatory compliance of a new share issue rather than a financial report or earnings release. This matches the definition of a Share Issue/Capital Change announcement (SHA). The document is lengthy (15,000 characters) and contains substantive details about the capital change, not just a brief notice or a report publication announcement. Therefore, the correct classification is SHA with high confidence.
2013-12-01 English
Entitlement Issue S708AA Notice 2 pages 48.8KB
Capital/Financing Update Classification · 95% confidence The document is a notice given under section 708AA of the Corporations Act related to an underwritten entitlement issue to raise capital by issuing new shares. It discusses the effect of the offer on shareholding and voting power, referencing compliance with disclosure requirements and the Corporations Act. The document is essentially an announcement about a capital raising event and the associated shareholding implications. It does not contain financial statements or detailed financial performance data, nor is it a full report or a certification. The document length is 4709 characters, which is relatively short and focused on the capital raising notice. Therefore, this fits best under the category of Capital/Financing Update (CAP).
2013-12-01 English
Presentation to Shareholders 22 pages 4.7MB
Investor Presentation Classification · 95% confidence The document is a detailed corporate update presentation from November 2013 by Phylogica, covering business overview, technology introduction, partnerships, recent highlights, recapitalization strategy, shareholder information, and strategic plans. It includes financial and corporate information such as share issuance, rights issue details, shareholder percentages, and business development milestones. The document is not a formal financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement or certification. It is a comprehensive corporate update presentation aimed at investors and stakeholders, focusing on company strategy, technology, partnerships, and financing activities. Therefore, it fits best as an Investor Presentation (IP). The document length (6235 characters) and content support this classification with high confidence.
2013-11-27 English
Results of Meeting 1 page 19.6KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'ANNUAL GENERAL MEETING RESULTS' and provides detailed voting outcomes for resolutions considered at the AGM of Phylogica Limited. It includes vote counts for each resolution, mentions the passing of resolutions, and references the Corporations Act and listing rules. The document is short (1825 characters) and focuses solely on the results of shareholder voting at the AGM, not on the full AGM materials or presentations. Therefore, it is not an Annual Report or Proxy Solicitation but specifically the Declaration of Voting Results from the AGM.
2013-11-27 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.